Abstract
The possibility of using technetium-99m(V) dimercaptosuccinic acid, Tc- 99m DMSA, in the evaluation of uveal amelanotic melanoma was assessed in this study. Both planar and SPECT images clearly demonstrated the tumor. Following confirmation of our results by contemporaneous ultrasonography and MRI the patient was treated with Iodine-125 brachytherapy. In combination with other diagnostic tests, Tc-99m(V) DMSA scintigraphy may play a role in the detection of uveal melanoma and its possible systemic metastases.
| Original language | English |
|---|---|
| Pages (from-to) | 147-149 |
| Number of pages | 3 |
| Journal | Annals of Nuclear Medicine |
| Volume | 11 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - May 1997 |
Keywords
- MRI
- Tc-99m(V) DMSA
- Uveal amelanotic melanoma
Fingerprint
Dive into the research topics of 'Visualization of uveal amelanotic melanoma with technetium-99m(V) dimercaptosuccinic acid'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver